by Mia Sato on (#5H77A)
Last week US regulators recommended resuming use of the Johnson & Johnson vaccine, after deciding that a side effect involving blood clots was too rare to justify continuing the brief suspension they had imposed: there were just 15 reported instances out of 8 million doses. But even though the pause lasted just 11 days, it…